CNTB logo

Connect Biopharma Holdings Limited (CNTB)

Profile

Full Name

Connect Biopharma Holdings Limited

Ticker

NASDAQ: CNTB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 19, 2021

Indexes

Not included

Website

https://www.connectbiopharm.com

Employees

62

Key Details

Price

$1.88(-2.08%)

Market cap

$104.45M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$26.05M(+100.00% YoY)

Annual EPS

-$0.28(+75.19% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.88
    CNTB price is $1.88

    30-Day Relative Volume

    0.90
    CNTB 30-day relative volume is 0.90

    Price Performance

    Price Today change

    -2.08%
    CNTB price is down -2.08% today

    Price YTD change

    +36.23%
    CNTB price is up +36.23% since January 1st

    Price 1-year change

    +64.91%
    CNTB price is up +64.91% year-on-year

    Price 3-year change

    +37.23%
    CNTB price is up +37.23% over the past 3 years

    Price Range

    Price All-time high

    $29.27
    CNTB price is currently -93.58% below its historical high of $29.27

    Price 3-year low

    $0.51
    CNTB price is currently +268.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $104.45M
    CNTB market capitalization is $104.45 million

    Market cap 3-year change

    +38.59%
    CNTB market capitalization is up +38.59% over the past 3 years

    Market cap All-time high

    $1.57B
    CNTB market capitalization is currently -93.35% below its historical high of $1.57 billion

    Market cap sector rank

    43.62%
    CNTB market capitalization is higher than 43.62% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.56%
    CNTB shares outstanding is up +0.56% year-on-year

    Shares Outstanding 3-Year Change

    +0.99%
    CNTB shares outstanding is up +0.99% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.61
    CNTB beta is 0.61

    200-day SMA

    $1.07
    CNTB price is currently +75.11% above its 200-day simple moving average

    50-day SMA

    $1.54
    CNTB price is currently +22.39% above its 50-day simple moving average

    RSI

    50.04
    CNTB 14-day relative strength index is 50.04

    Volume

    0.90
    CNTB 30-day relative volume is 0.90

    ATR

    $0.29
    CNTB average true range is $0.29

    10-day Historical Volatility

    99.06%
    CNTB 10-day historical volatility is 99.06%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $26.05M
    CNTB annual revenue is $26.05 million

    Revenue Analysts estimate

    -
    CNTB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +100%
    CNTB annual revenue is up +100% year-on-year

    Revenue Sector rank

    54.45%
    CNTB annual revenue is higher than 54.45% of companies in Healthcare sector

    EPS

    EPS

    -$0.28
    CNTB annual earnings per share is -$0.28

    EPS Analysts estimate

    -$0.91
    CNTB annual earnings per share is currently -69.33% lower than the consensus analysts' forecast

    EPS 1-year change

    +75.19%
    CNTB annual earnings per share is up +75.19% year-on-year

    EPS Sector rank

    68.85%
    CNTB annual earnings per share is higher than 68.85% of companies in Healthcare sector

    Profit

    Gross profit

    $25.39M
    CNTB annual gross profit is $25.39 million

    Gross margin

    97.46%
    CNTB annual gross profit margin is 97.46%

    Operating profit

    -$22.46M
    CNTB annual operating income is -$22.46 million

    Operating margin

    -86.24%
    CNTB annual operating profit margin is -86.24%

    Net income

    -$15.64M
    CNTB annual net profit is -$15.64 million

    Net margin

    -60.03%
    CNTB annual net profit margin is -60.03%

    Expenses

    Total expenses

    $41.68M
    CNTB annual total expenses is $41.68 million

    Operating expenses

    $47.85M
    CNTB annual total operating expenses is $47.85 million

    Cost of goods sold

    $660.30K
    CNTB annual cost of goods sold is $660.30 thousand

    Selling, general & administrative expenses

    $0.00
    CNTB annual SGA is $0.00

    Depreciation and amortization

    $660.30K
    CNTB annual depreciation & amortization is $660.30 thousand

    Interest expense

    $0.00
    CNTB annual interest expense is $0.00

    Income tax

    $223.10K
    CNTB annual income tax is $223.10 thousand

    EBIT & EBITDA

    EBIT

    -$22.46M
    CNTB annual earnings before interest & taxes is -$22.46 million

    EBITDA

    -$21.80M
    CNTB annual EBITDA is -$21.80 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $101.28M
    CNTB annual total assets is $101.28 million

    Non current assets

    $4.32M
    CNTB annual long term assets is $4.32 million

    Current assets

    $96.96M
    CNTB annual total current assets is $96.96 million

    Cash and cash equivalents

    $93.71M
    CNTB annual cash & cash equivalents is $93.71 million

    Accounts receivable

    $789.00K
    CNTB annual accounts receivable is $789.00 thousand

    Inventory

    $0.00
    CNTB annual inventory is $0.00

    Liabilities

    Total liabilities

    $9.12M
    CNTB annual total liabilities is $9.12 million

    Long term liabilities

    $656.00K
    CNTB annual total long term liabilities is $656.00 thousand

    Current liabilities

    $8.46M
    CNTB annual total current liabilities is $8.46 million

    Accounts payable

    $342.00K
    CNTB annual accounts payable is $342.00 thousand

    Debt

    Total debt

    $178.00K
    CNTB annual total debt is $178.00 thousand

    Total debt 1-year change

    -61.72%
    CNTB annual total debt is down -61.72% year-on-year

    Long term debt

    $24.00K
    CNTB annual long term debt is $24.00 thousand

    Short term debt

    $154.00K
    CNTB annual short term debt is $154.00 thousand

    Equity & Capital

    Shareholders equity

    $92.17M
    CNTB annual stockholders equity is $92.17 million

    Book value

    $92.17M
    CNTB annual book value is $92.17 million

    Retained earnings

    -$345.35M
    CNTB annual retained earnings is -$345.35 million

    Working capital

    $88.50M
    CNTB annual working capital is $88.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$23.62M
    CNTB annual cash flow from operations is -$23.62 million

    Cash from operations 1-year change

    +50.47%
    CNTB annual cash flow from operations is up +50.47% year-on-year

    Cash from investing

    -$3.45M
    CNTB annual cash flow from investing activities is -$3.45 million

    Cash from investing 1-year change

    -104.61%
    CNTB annual cash flow from investing activities is down -104.61% year-on-year

    Cash from financing

    $227.10K
    CNTB annual cash flow from financing activities is $227.10 thousand

    Cash from financing 1-year change

    +404.67%
    CNTB annual cash flow from financing activities is up +404.67% year-on-year

    CAPEX

    CAPEX

    $750.40K
    CNTB annual capital expenditures is $750.40 thousand

    CAPEX 1-year change

    +827.56%
    CNTB annual capital expenditures is up +827.56% year-on-year

    Free Cash Flow

    Free cash flow

    -$24.37M
    CNTB annual free cash flow is -$24.37 million

    Free cash flow 1-year change

    +48.99%
    CNTB annual free cash flow is up +48.99% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    97.46%
    CNTB annual gross profit margin is 97.46%

    Operating margin

    -86.24%
    CNTB annual operating profit margin is -86.24%

    Net margin

    -60.03%
    CNTB annual net profit margin is -60.03%

    ROA & ROE

    ROA

    -13.68%
    CNTB annual return on assets is -13.68%

    ROE

    -16.15%
    CNTB annual return on equity is -16.15%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CNTB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CNTB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.46
    CNTB price to book ratio is 1.46

    PB ratio Sector rank

    47.05%
    CNTB price to book ratio is higher than 47.05% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2167.11
    CNTB price to sales ratio is 2167.11

    PS ratio Sector rank

    98.77%
    CNTB price to sales ratio is higher than 98.77% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $32.69M
    CNTB enterprise value is $32.69 million

    Enterprise value Sector rank

    37.48%
    CNTB enterprise value is higher than 37.48% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.33
    CNTB EV/EBITDA is -1.33

    EV/EBITDA Sector rank

    40.69%
    CNTB EV/EBITDA is higher than 40.69% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    11.46
    CNTB annual current ratio is 11.46

    Quick ratio

    11.46
    CNTB annual quick ratio is 11.46

    Leverage

    Debt to equity

    0.00
    CNTB annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CNTB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CNTB piotroski f-score value is unknown

    Altman Z-Score

    2.67
    CNTB altman z-score is 2.67

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Sep 6, 24 HC Wainwright & Co.
    Buy
    Jun 13, 24 HC Wainwright & Co.
    Buy
    Apr 17, 24 HC Wainwright & Co.
    Buy
    Mar 4, 24 HC Wainwright & Co.
    Buy
    Sep 13, 23 Cantor Fitzgerald
    Overweight
    Feb 8, 23 SVB Leerink
    Outperform
    Jun 2, 22 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with CNTB included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Connect Biopharma Holdings Limited?
    • Does Connect Biopharma Holdings Limited pay dividends?
    • What sector is Connect Biopharma Holdings Limited in?
    • What industry is Connect Biopharma Holdings Limited in?
    • What country is Connect Biopharma Holdings Limited based in?
    • When did Connect Biopharma Holdings Limited go public?
    • Is Connect Biopharma Holdings Limited in the S&P 500?
    • Is Connect Biopharma Holdings Limited in the NASDAQ 100?
    • Is Connect Biopharma Holdings Limited in the Dow Jones?
    • When was Connect Biopharma Holdings Limited's last earnings report?
    • When does Connect Biopharma Holdings Limited report earnings?

    What is the ticker symbol for Connect Biopharma Holdings Limited?

    The ticker symbol for Connect Biopharma Holdings Limited is NASDAQ:CNTB

    Does Connect Biopharma Holdings Limited pay dividends?

    No, Connect Biopharma Holdings Limited does not pay dividends

    What sector is Connect Biopharma Holdings Limited in?

    Connect Biopharma Holdings Limited is in the Healthcare sector

    What industry is Connect Biopharma Holdings Limited in?

    Connect Biopharma Holdings Limited is in the Biotechnology industry

    What country is Connect Biopharma Holdings Limited based in?

    Connect Biopharma Holdings Limited is headquartered in United States

    When did Connect Biopharma Holdings Limited go public?

    Connect Biopharma Holdings Limited's initial public offering (IPO) was on March 19, 2021

    Is Connect Biopharma Holdings Limited in the S&P 500?

    No, Connect Biopharma Holdings Limited is not included in the S&P 500 index

    Is Connect Biopharma Holdings Limited in the NASDAQ 100?

    No, Connect Biopharma Holdings Limited is not included in the NASDAQ 100 index

    Is Connect Biopharma Holdings Limited in the Dow Jones?

    No, Connect Biopharma Holdings Limited is not included in the Dow Jones index

    When was Connect Biopharma Holdings Limited's last earnings report?

    Connect Biopharma Holdings Limited's most recent earnings report was on March 30, 2023

    When does Connect Biopharma Holdings Limited report earnings?

    The date for Connect Biopharma Holdings Limited's next earnings report has not been announced yet
    On this page